{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:22:11Z","timestamp":1789240931380,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":152,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1148595"],"award-info":[{"award-number":["1148595"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100420","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T13:07:20Z","timestamp":1623157640000},"page":"100420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review"],"prefix":"10.1016","volume":"28","author":[{"given":"Ellen M. Lavoie","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Kuisell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Kanzawa-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna B.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2021.100420_bib0001","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA. Canc. J. Clin."},{"key":"10.1016\/j.ctarc.2021.100420_bib0002","first-page":"2569","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the st jude lifetime cohort study (sjlife)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet(LDN. ENGL.)"},{"key":"10.1016\/j.ctarc.2021.100420_bib0003","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","article-title":"Survivors of childhood cancer in the United States: prevalence and burden of morbidity","volume":"24","author":"Phillips","year":"2015","journal-title":"Canc. Epidemiol. Biomarker. Prev"},{"key":"10.1016\/j.ctarc.2021.100420_bib0004","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/S2352-3026(19)30050-X","article-title":"The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the st jude lifetime cohort study","volume":"6","author":"Mulrooney","year":"2019","journal-title":"Lance. Haematol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pbc.26204","article-title":"Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-cns cancer","volume":"64","author":"Gilchrist","year":"2017","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0006","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S2352-4642(18)30236-0","article-title":"Peripheral neuropathy in children and adolescents treated for cancer","volume":"2","author":"Bjornard","year":"2018","journal-title":"Lance. Chil. Adolesc. Heal"},{"key":"10.1016\/j.ctarc.2021.100420_bib0007","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: asco guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0008","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: esmo\u2013eons\u2013eano clinical practice guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0009","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.ctarc.2021.100420_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctrv.2016.09.005","article-title":"Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge","volume":"50","author":"Kandula","year":"2016","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.ctarc.2021.100420_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2018.05.011","article-title":"Neurological complications of the treatment of pediatric neoplastic disorders","volume":"85","author":"Sun","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2017.04.004","article-title":"Vincristine-induced peripheral neuropathy in children with cancer: a systematic review","volume":"114","author":"van de Velde","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the prisma statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS. Med."},{"key":"10.1016\/j.ctarc.2021.100420_bib0014","first-page":"147","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"JBI. Evid. Implem."},{"key":"10.1016\/j.ctarc.2021.100420_bib0015","unstructured":"Institute T.J.B. Joanna Briggs Institute Critical Appraisal Tools. 2017. http:\/\/joannabriggs-webdev.org\/research\/critical-appraisal-tools.html (accessed May 7, 2020)."},{"key":"10.1016\/j.ctarc.2021.100420_bib0016","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/pbc.25384","article-title":"Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer","volume":"62","author":"Bradfield","year":"2015","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2018.05.002","article-title":"Phase I results of a phase i\/ii study of weekly nab-paclitaxel in paediatric patients with recurrent\/refractory solid tumours: a collaboration with innovative therapies for children with cancer","volume":"100","author":"Moreno","year":"2018","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12185-017-2235-z","article-title":"Bortezomib combined with standard induction chemotherapy in japanese children with refractory acute lymphoblastic leukemia","volume":"106","author":"Iguchi","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0019","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/MPH.0b013e3181e9038d","article-title":"A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study","volume":"32","author":"Mokhtar","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPH.0000000000000910","article-title":"Association of cyp3a5 expression and vincristine neurotoxicity in pediatric malignancies in turkish population","volume":"39","author":"Kayilio\u011flu","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0021","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1078155214553143","article-title":"The effect of race on the cyp3a-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia","volume":"22","author":"Sims","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ctarc.2021.100420_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7123\/01.ERR.0000426384.78772.59","article-title":"Electrophysiological study of peripheral nerves in children with acute lymphoblastic leukemia","volume":"40","author":"Ibrahim","year":"2013","journal-title":"Egypt Rheumatol. Rehabil."},{"key":"10.1016\/j.ctarc.2021.100420_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08880018.2019.1677832","article-title":"Vincristine-induced peripheral neurotoxicity: a prospective cohort","volume":"37","author":"Nama","year":"2020","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PEP.0000000000000484","article-title":"Short-term recovery of balance control: association with chemotherapy-induced peripheral neuropathy in pediatric oncology","volume":"30","author":"Gilchrist","year":"2018","journal-title":"Pediatr. Phys. Ther."},{"key":"10.1016\/j.ctarc.2021.100420_bib0025","first-page":"425","article-title":"Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study","volume":"18","author":"Wahba","year":"2013","journal-title":"J. BUON."},{"key":"10.1016\/j.ctarc.2021.100420_bib0026","doi-asserted-by":"crossref","first-page":"e27351","DOI":"10.1002\/pbc.27351","article-title":"Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas","volume":"65","author":"Rosca","year":"2018","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0027","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0317167100018461","article-title":"Chemotherapy-induced peripheral neuropathy among paediatric oncology patients","volume":"41","author":"Purser","year":"2014","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ctarc.2021.100420_bib0028","doi-asserted-by":"crossref","first-page":"e26677","DOI":"10.1002\/pbc.26677","article-title":"Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in oman: frequent autonomic and more severe cranial nerve involvement","volume":"64","author":"Nazir","year":"2017","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0029","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1440-1754.2011.02103.x","article-title":"Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach","volume":"47","author":"Moore","year":"2011","journal-title":"J. Paediatr. Child Heal."},{"key":"10.1016\/j.ctarc.2021.100420_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22845","article-title":"Increased risk of vincristine neurotoxicity associated with low cyp3a5 expression genotype in children with acute lymphoblastic leukemia","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ctarc.2021.100420_bib0032","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1097\/NCC.0b013e318299ad23","article-title":"Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"36","author":"Smith","year":"2013","journal-title":"Canc. Nurs."},{"key":"10.1016\/j.ctarc.2021.100420_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26854","article-title":"CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in kenyan children with cancer","volume":"65","author":"Skiles","year":"2018","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0034","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/FPC.0000000000000345","article-title":"Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in arab children treated for acute childhood leukemia: a single institution study","volume":"28","author":"Zgheib","year":"2018","journal-title":"Pharmacogenet. Genomi."},{"key":"10.1016\/j.ctarc.2021.100420_bib0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pbc.23039","article-title":"Neuropathic pain during treatment for childhood acute lymphoblastic leukemia","volume":"57","author":"Anghelescu","year":"2011","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0036","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/MPH.0000000000000321","article-title":"Vincristine-associated neurological morbidity in the treatment of hepatoblastoma","volume":"37","author":"Lombardi","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/08880018.2019.1637981","article-title":"Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies","volume":"36","author":"Dudeja","year":"2019","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0038","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.ctarc.2021.100420_bib0039","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2017.12.010","article-title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","volume":"65","author":"Millan","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ctarc.2021.100420_bib0040","first-page":"S393","article-title":"Chemotherapy-induced peripheral neuropathy in non-cns cancers: comparison between diagnostic groups","volume":"61","author":"Gilchrist","year":"2014","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0041","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0883073811428379","article-title":"Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia","volume":"27","author":"Brigo","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0042","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/mus.24647","article-title":"Vincristine-induced neuropathy: atypical electrophysiological patterns in children","volume":"52","author":"Courtemanche","year":"2015","journal-title":"Muscl. Nerv."},{"key":"10.1016\/j.ctarc.2021.100420_bib0043","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0044","doi-asserted-by":"crossref","first-page":"e11844","DOI":"10.5812\/ijp.11844","article-title":"Chemotherapy-induced peripheral neuropathy in a subpopulation of mexican pediatric patients with acute lymphoblastic leukemia","volume":"27","author":"Vivas-Rosales","year":"2017","journal-title":"Iran. J. Pediatr."},{"key":"10.1016\/j.ctarc.2021.100420_bib0045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0883073813491829","article-title":"Vincristine-induced neuropathy in childhood all (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics","volume":"29","author":"Jain","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0046","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0008417414539926","article-title":"Vincristine and fine motor function of children with acute lymphoblastic leukemia","volume":"81","author":"Sabarre","year":"2014","journal-title":"Can. J. Occup. Ther."},{"key":"10.1016\/j.ctarc.2021.100420_bib0047","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.REO.0000000000000152","article-title":"Multidimensional outcome measurement of children and youth with neuropathy following treatment of leukemia: cross-sectional descriptive report","volume":"37","author":"Wright","year":"2019","journal-title":"Rehabil. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0048","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/01616412.2016.1139321","article-title":"Vincristine-induced neurotoxicity: electrophysiological features in children","volume":"38","author":"Yildiz","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ctarc.2021.100420_bib0049","doi-asserted-by":"crossref","first-page":"e26471","DOI":"10.1002\/pbc.26471","article-title":"Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia","volume":"64","author":"Tay","year":"2017","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejpn.2017.12.019","article-title":"Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia","volume":"22","author":"Lieber","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0051","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gaitpost.2017.05.004","article-title":"Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia","volume":"58","author":"Wright","year":"2017","journal-title":"Gait. Postu."},{"key":"10.1016\/j.ctarc.2021.100420_bib0052","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12098-009-0254-3","article-title":"Vincristine induced neurotoxicity in cancer patients","volume":"77","author":"Gomber","year":"2010","journal-title":"Ind. J. Pediatr."},{"key":"10.1016\/j.ctarc.2021.100420_bib0053","first-page":"2867","article-title":"Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the dutch pediatric\u2013modified total neuropathy score","volume":"28","author":"Schouten","year":"2020","journal-title":"Suppo. Care Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0054","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood-2015-01-621680","article-title":"Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia","volume":"125","author":"Ness","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.ctarc.2021.100420_bib0055","first-page":"847","article-title":"The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-cns cancers","volume":"21","author":"Gilchrist","year":"2013","journal-title":"Suppo. Care Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0056","first-page":"359","article-title":"Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children","volume":"22","author":"Gilchrist","year":"2014","journal-title":"Suppo. Care Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0057","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2017.12.010","article-title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","volume":"65","author":"Millan","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ctarc.2021.100420_bib0058","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1097\/MPH.0000000000001604","article-title":"Obesity as a potential risk factor for vincristine-induced peripheral neuropathy","volume":"42","author":"ajdyk","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021734","article-title":"Psychometric properties of gross motor assessment tools for children: a systematic review","volume":"8","author":"Griffiths","year":"2018","journal-title":"BMJ. Open."},{"key":"10.1016\/j.ctarc.2021.100420_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.gaitpost.2008.05.001","article-title":"The gait deviation index: a new comprehensive index of gait pathology","volume":"28","author":"Schwartz","year":"2008","journal-title":"Gait Postu."},{"key":"10.1016\/j.ctarc.2021.100420_bib0061","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u2018up & go\u2019: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0062","first-page":"S117","article-title":"Genetic polymorphisms in candidate genes including cep72 are not associated with increased vincristine-related peripheral neuropathy in arab children treated for acute childhood leukemia","volume":"65","author":"Ghanem","year":"2018","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0063","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/brain\/119.6.2039","article-title":"A prospective study of suramin-induced peripheral neuropathy","volume":"119","author":"Chaudhry","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.ctarc.2021.100420_bib0064","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/S2352-3026(20)30064-8","article-title":"Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review","volume":"7","author":"Smith","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0065","first-page":"96","article-title":"The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy","volume":"35","author":"Smith","year":"2008","journal-title":"Oncol. Nurs. For."},{"key":"10.1016\/j.ctarc.2021.100420_bib0066","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01893697-200927030-00002","article-title":"Measuring chemotherapy-induced peripheral neuropathy in children: development of the ped-mtns and pilot study results","volume":"27","author":"Gilchrist","year":"2009","journal-title":"Rehabil. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0067","doi-asserted-by":"crossref","first-page":"FV01","DOI":"10.1055\/s-0036-1583708","article-title":"Quantitative sensory testing is highly sensitive in detecting chemotherapy-induced peripheral neuropathy","volume":"47","author":"Lieber","year":"2016","journal-title":"Neuropediatr."},{"key":"10.1016\/j.ctarc.2021.100420_bib0068","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1998.16.3.1188","article-title":"Health-related quality of life in the general norwegian population assessed by the european organization for research and treatment of cancer core quality-of-life questionnaire: the qlq=c30 (+ 3)","volume":"16","author":"Hjermstad","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0069","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01893697-201230010-00013","article-title":"Comparison of 2 measures of chemotherapyinduced peripheral neuropathy in schoolaged children undergoing neurotoxic cancer treatment","volume":"30","author":"Marais","year":"2012","journal-title":"Rehabil. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0070","first-page":"S148","article-title":"The absence of vincristine neuropathy in Kenyan children with cancer: the good, the bad, and the (possibly) ugly","volume":"63","author":"Skiles","year":"2016","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0071","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2019-126532","article-title":"Vincristine-induced peripheral neuropathy in pediatric oncology patients receiving vincristine through push injections or one-hour infusions: results of a randomized clinical trial","volume":"134","author":"Van De Velde","year":"2019","journal-title":"Blood ."},{"key":"10.1016\/j.ctarc.2021.100420_bib0072","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the st. jude lifetime cohort study","volume":"94","author":"Ness","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ctarc.2021.100420_bib0073","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1529-8027.2011.00351.x","article-title":"Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the national cancer institute common toxicity scale","volume":"16","author":"Frigeni","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ctarc.2021.100420_bib0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jns.12333","article-title":"Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity","volume":"24","author":"Park","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ctarc.2021.100420_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14694\/EdBook_AM.2014.34.161","article-title":"The rationale for collecting patient-reported symptoms during routine chemotherapy","volume":"34","author":"Basch","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"10.1016\/j.ctarc.2021.100420_bib0076","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdt409","article-title":"Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin","volume":"25","author":"Alberti","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2021.100420_bib0077","first-page":"133","article-title":"The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums","volume":"38","author":"Lavoie Smith","year":"2011","journal-title":"Oncol. Nurs. For."},{"key":"10.1016\/j.ctarc.2021.100420_bib0078","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ctarc.2021.100420_bib0079","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1023\/A:1008344507482","article-title":"Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy","volume":"9","author":"Postma","year":"1998","journal-title":"Ann. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:21:09Z","timestamp":1762842069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":79,"alternative-id":["S2468294221001180"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100420","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100420"}}